These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 178794)

  • 1. Studies on the terminal stages of antibody-complement-mediated killing of a tumor cell. II. Inhibition of transformation of T to dead cells by 3'5' cAMP.
    Boyle MD; Ohanian SH; Borsos T
    J Immunol; 1976 May; 116(5):1276-9. PubMed ID: 178794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the terminal stages of antibody-complement-mediated killing of a tumor cell. I. Evidence for the existence of an intermediate, T.
    Boyle MD; Ohanian SH; Borsos T
    J Immunol; 1976 May; 116(5):1272-5. PubMed ID: 178793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of antibody-complement-mediated killing of tumor cells by hormones.
    Schlager SI; Ohanian SH; Borsos T
    Cancer Res; 1976 Oct; 36(10):3672-7. PubMed ID: 182362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the terminal stages of antibody-complement mediated killing of a tumor cell. III. Effect of membrane active agents.
    Boyle MD; Ohanian SH; Borsos T
    J Immunol; 1976 Jul; 117(1):106-9. PubMed ID: 932422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between the intracellular cyclic adenosine 3':5'-monophosphate level of tumor cells and their sensitivity to killing by antibody and complement.
    Lo TN; Boyle MD
    Cancer Res; 1979 Aug; 39(8):3156-62. PubMed ID: 222445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of inhibiting DNA, RNA, and protein synthesis of tumor cells on their susceptibility to killing by antibody and complement.
    Schlager SI; Boyle MD; Ohanian SH; Borsos T
    Cancer Res; 1977 May; 37(5):1432-7. PubMed ID: 192450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of hormone-induced tumor cell resistance to killing by antibody and complement.
    Schlager SI; Ohanian SH; Borsos T
    Cancer Res; 1977 Mar; 37(3):765-70. PubMed ID: 189914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of concanavalin A on the killing of tumor cells by antibody and complement.
    Boyle MD; Langone JJ; Ohanian SH; Borsos T
    J Immunol; 1977 May; 118(5):1626-30. PubMed ID: 192797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysis of tumor cells by antibody and complement. VII. Complement-dependent 86Rb release--a nonlethal event?
    Boyle MD; Ohanian SH; Borsos T
    J Immunol; 1976 Oct; 117(4):1346-50. PubMed ID: 185297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of inhibitory activity for B cell differentiation in human CD8 T cells with pokeweed mitogen, dimaprit, and cAMP upregulating agents: countersuppressive effect of platelet factor 4.
    Crisi GM; Katz IR; Zucker MB; Thorbecke GJ
    Cell Immunol; 1996 Sep; 172(2):205-16. PubMed ID: 8964082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
    Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
    Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing effect by metabolic inhibitors on the killing of tumor cells by antibody and complement.
    Segerling M; Ohanian SH; Borsos T
    Cancer Res; 1975 Nov; 35(11 Pt 1):3195-203. PubMed ID: 52404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between the ability of tumor cells to incorporate specific fatty acids and their sensitivity to killing by a specific antibody plus guinea pig complement.
    Schlager SI; Ohanian SH; Borsos T
    J Natl Cancer Inst; 1978 Sep; 61(3):931-4. PubMed ID: 278869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic inhibition of growth of breast and colon human cancer cell lines by site-selective cyclic AMP analogues.
    Tagliaferri P; Katsaros D; Clair T; Ally S; Tortora G; Neckers L; Rubalcava B; Parandoosh Z; Chang YA; Revankar GR
    Cancer Res; 1988 Mar; 48(6):1642-50. PubMed ID: 2830966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of cyclic-AMP responsive element binding (CREB) proteins in cell proliferation in a rat model of hepatocellular carcinoma.
    Kovach SJ; Price JA; Shaw CM; Theodorakis NG; McKillop IH
    J Cell Physiol; 2006 Feb; 206(2):411-9. PubMed ID: 16110470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody binding to CD5 (Tp67) and Tp44 T cell surface molecules: effects on cyclic nucleotides, cytoplasmic free calcium, and cAMP-mediated suppression.
    Ledbetter JA; Parsons M; Martin PJ; Hansen JA; Rabinovitch PS; June CH
    J Immunol; 1986 Nov; 137(10):3299-305. PubMed ID: 3021852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of catecholamine-mediated destabilization of messenger RNA encoding Thy-1 protein in T-lineage cells.
    Wajeman-Chao SA; Lancaster SA; Graf LH; Chambers DA
    J Immunol; 1998 Nov; 161(9):4825-33. PubMed ID: 9794415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysis of tumor cells by antibody and complement. VI. Enhanced killing of enzyme-pretreated tumor cells.
    Boyle MD; Ohanian SH; Borsos T
    J Immunol; 1976 Mar; 116(3):661-8. PubMed ID: 176270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma membrane and intracellular lipid synthesis in tumor cells rendered resistant to humoral immune killing after treatment with hormones.
    Schlager SI; Ohanian SH
    J Natl Cancer Inst; 1980 Apr; 64(4):943-50. PubMed ID: 6988626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.